As the indications for hematopoietic cell transplantation (HCT) expand, understanding the impact of pre-transplantation disparities may help providers identify risk factors and inform interventions. This article explores the impact of race, neighborhood poverty and insurance on pediatric HCT outcomes.
New protocol for bone marrow transplant (BMT) for sickle cell disease is changing the face of transplant. A recent case highlights the difference this new protocol can make.
Cure sometimes, treat often, care always. Find out what inspired Dr. Rabi Hanna to help people when they are sick and vulnerable by healing and helping them.
Cleveland Clinic now offers bone marrow transplantation for sickle cell disease, giving 90 percent of patients the chance of being cured.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
New hope for patients with no bone marrow donor match
Research advances, better treatment protocols improve outcomes